You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 29, 2024

Investigational Drug Information for BLU-5937

✉ Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug BLU-5937?

BLU-5937 is an investigational drug.

There have been 9 clinical trials for BLU-5937. The most recent clinical trial was a Phase 1 trial, which was initiated on October 1st 2022.

The most common disease conditions in clinical trials are Cough, Eczema, and Dermatitis, Atopic. The leading clinical trial sponsors are Bellus Health Inc and [disabled in preview].

There are four US patents protecting this investigational drug and fifty-two international patents.

Recent Clinical Trials for BLU-5937
Evaluation of the Effect of Rifampin and Rabeprazole on the Pharmacokinetics of CamlipixantBellus Health IncPhase 1
Assessment of the Pharmacokinetics of BLU-5937 Extended Release FormulationBellus Health IncPhase 1
A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic CoughBellus Health IncPhase 3

See all BLU-5937 clinical trials

Clinical Trial Summary for BLU-5937

Top disease conditions for BLU-5937
Top clinical trial sponsors for BLU-5937

See all BLU-5937 clinical trials

US Patents for BLU-5937

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
BLU-5937 ⤷  Sign Up Selective P2X3 modulators BELLUS HEALTH COUGH INC. (Laval, Quebec, CA) NEOMED INSTITUTE (Montreal, Quebec, CA) ⤷  Sign Up
BLU-5937 ⤷  Sign Up Imidazopyridine compounds and uses thereof Neomed Institute (Montreal, Quebec, CA) ⤷  Sign Up
BLU-5937 ⤷  Sign Up Method of treatment of chronic cough administering orvepitant in combination with other therapeutic agents NeRRe Therapeutics Limited (Herts, GB) ⤷  Sign Up
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.